Vanguard Group Inc. Lowers Stock Position in The Clorox Company $CLX

Key Points

• Vanguard Group trimmed its Clorox stake by 0.3% in Q4, selling 54,681 shares and now owns 15,684,000 shares (12.86%) valued at about $1.581 billion.
• Clorox beat Q3 EPS estimates ($1.64 vs. $1.55) but warned of weaker demand and rising costs, lowering FY2026 guidance and sparking share weakness toward 52‑week lows and analyst target cuts.
• The company announced a quarterly dividend of $1.24 (annualized $4.96) for a 5.1% yield, while the stock trades near its one‑year low with a consensus target around $111.33.

Vanguard Group Inc. cut its holdings in shares of The Clorox Company (NYSE:CLX - Free Report) by 0.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 15,684,000 shares of the company's stock after selling 54,681 shares during the period. Vanguard Group Inc. owned 12.86% of Clorox worth $1,581,418,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Center for Financial Planning Inc. purchased a new position in shares of Clorox during the third quarter worth approximately $25,000. Vermillion & White Wealth Management Group LLC purchased a new position in shares of Clorox during the third quarter worth approximately $25,000. True Wealth Design LLC grew its position in shares of Clorox by 1,020.0% during the third quarter. True Wealth Design LLC now owns 224 shares of the company's stock worth $28,000 after acquiring an additional 204 shares during the last quarter. Root Financial Partners LLC purchased a new position in shares of Clorox during the third quarter worth approximately $29,000. Finally, Darwin Wealth Management LLC purchased a new position in shares of Clorox during the second quarter worth approximately $29,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Stock Performance

NYSE:CLX opened at $96.48 on Friday. The firm's fifty day moving average price is $108.21 and its 200 day moving average price is $108.82. The Clorox Company has a 1-year low of $93.39 and a 1-year high of $141.50. The company has a debt-to-equity ratio of 71.03, a current ratio of 0.74 and a quick ratio of 0.48. The firm has a market cap of $11.66 billion, a price-to-earnings ratio of 15.76, a price-to-earnings-growth ratio of 0.47 and a beta of 0.65.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, beating analysts' consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.17% and a return on equity of 383.01%. The firm had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same period last year, the firm posted $1.45 EPS. Clorox's quarterly revenue was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, sell-side analysts expect that The Clorox Company will post 5.87 EPS for the current year.

Clorox Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 8th. Shareholders of record on Wednesday, April 22nd will be issued a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, April 22nd. This represents a $4.96 dividend on an annualized basis and a yield of 5.1%. Clorox's dividend payout ratio (DPR) is 81.05%.

More Clorox News

Here are the key news stories impacting Clorox this week:

• Positive Sentiment: Q3 EPS beat and revenue roughly in line — Clorox reported $1.64 EPS, ahead of consensus, and quarterly revenue was essentially flat year‑over‑year, which helped calm some near‑term earnings concerns. Clorox Reports Q3 Fiscal Year 2026 Results, Updates Outlook
• Positive Sentiment: Underlying profit beat consensus — multiple outlets note non‑GAAP EPS topped estimates (~$1.64 vs. ~$1.55), signaling better-than-expected margin or cost management in the quarter. Clorox (CLX) Beats Q3 Earnings and Revenue Estimates
• Neutral Sentiment: Full earnings call transcript available — the conference call contains management color on categories, pricing, promotions and cost actions that investors should read for guidance on margin trajectory. Q3 2026 Earnings Call Transcript
• Neutral Sentiment: After‑hours/market reaction noted by mover lists — CLX showed up on after‑hours mover rundowns, indicating heightened trading and volatility around the print. After-hours movers: AAPL, ROKU, RBLX, TEAM, SNDK, RDDT, TWLO, CLX, WDC
• Negative Sentiment: Company lowered full‑year EPS guidance — management updated FY2026 EPS guidance below the Street’s prior consensus, signaling weaker near‑term growth than investors expected and weighing on sentiment. Compared to Estimates, Clorox (CLX) Q3 Earnings: A Look at Key Metrics
• Negative Sentiment: Management cited weaker demand and rising costs and cut profit outlook — outlets report a reduced annual profit forecast tied to softer consumer demand and cost pressure, a key downside catalyst for the stock. Clorox cuts annual profit forecast on weaker demand, rising costs
• Negative Sentiment: Shares hit new lows in immediate reaction — some coverage highlights shares trading near 52‑week lows after the update, underscoring investor concern about the outlook. Consumer Products Giant Clorox Shares Are Hitting New 52-Week Lows

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on CLX shares. Jefferies Financial Group lowered their target price on shares of Clorox from $151.00 to $139.00 and set a "buy" rating on the stock in a research report on Tuesday, April 21st. TD Cowen raised their target price on shares of Clorox from $98.00 to $111.00 and gave the stock a "hold" rating in a research report on Tuesday, March 31st. The Goldman Sachs Group lowered their price objective on shares of Clorox from $110.00 to $94.00 and set a "sell" rating on the stock in a research report on Wednesday, January 7th. Citigroup lowered their price objective on shares of Clorox from $115.00 to $110.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 15th. Finally, Rothschild & Co Redburn set a $117.00 price objective on shares of Clorox in a research report on Friday, February 13th. One investment analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have issued a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Reduce" and a consensus target price of $111.33.

Clorox Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company's flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox's diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.